| Net Cash Provided by (Used in) Operating Activities |
$332,000,000 |
USD |
44% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$386,000,000 |
USD |
51% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$268,000,000 |
USD |
-139% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
55,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
50 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$322,000,000 |
USD |
-348% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$352,000,000 |
USD |
-32% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$727,000,000 |
USD |
-15% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,104,000,000 |
USD |
133% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$112,000,000 |
USD |
-32% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$727,000,000 |
USD |
-15% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$2,000,000 |
USD |
0% |
Q4 2025 |
FY 2025 |